Residual tumor [Interpretation] Cancer Narrative --postoperative 81169-5
LOINC Code
LOINC code | 81169-5 | ||||
---|---|---|---|---|---|
name | Residual tumor [Interpretation] Cancer Narrative --postoperative | ||||
description | The surgeon's opinion on the existence of local residual cancer following an operative procedure. The interpretation may contain the overall completeness of resection of the tumor, including evidence of residual disease at surgical margins or within regions in which resection has not been attempted. | ||||
status | ACTIVE | ||||
Fully-Specified Name | |||||
component | Residual tumor^postoperative | ||||
property | Imp = Impression/interpretation of study | ||||
time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||||
system | Cancer.XXX | ||||
scale | Nar = Narrative: Text narrative, such as the description of a microscopic part of a surgical papule test. | ||||
method | |||||
Additional Names | |||||
short name | Residual tumor Postop Imp Cancer | ||||
Basic Attributes | |||||
class | SURG | ||||
type | 2 Clinical | ||||
order vs. observation | Observation | ||||
Associated Observations | |||||
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations. | |||||
Member of these Panels | |||||
| |||||
History/Usage | |||||
first released | |||||
last updated | 2.58 | ||||
last change type | MIN - change to field other than name | ||||
Related Names | |||||
|
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.